Search Results - matthias+majetschak

2 Results Sort By:
Use of Chemokine Receptor Antagonists for Fluid Resuscitation
­Advantages: Reduces amount of fluid required for resuscitation Reduces risk of complications New direction in critical care Summary: Our research focuses on improving the treatment of critically ill patients, especially those undergoing major surgery or suffering from conditions like severe burns, trauma, hemorrhage, or sepsis. Adequate...
Published: 9/21/2023   |   Inventor(s): Anthony DeSantis, Xianlong Gao, Matthias Majetschak
Keywords(s): Critical Care / Trauma, Medical Pharmaceuticals, Therapeutics
Category(s): Technology Classifications > Medical
Heteromers Between Chemokine Receptors And Alpha1-Adrenergic Receptors/Vasopressin Receptor 1A As Drug Targets To Modulate Inflammation And Cell Trafficking
­Advantaages: Novel therapeutic opportunities for modulating inflammation and cell trafficking Insights into neuroendocrine control of immune cell behavior Summary: This innovative technology centers around the discovery and characterization of heteromers formed between chemokine receptors (CR) and a1-adrenergic receptors (AR), specifically...
Published: 6/20/2024   |   Inventor(s): Matthias Majetschak
Keywords(s): Cancer Treatment, Therapeutics Cell Therapy
Category(s): Technology Classifications > Medical > Biomedical Engineering, Technology Classifications > Medical > Biotechnology, Technology Classifications > Medical > Therapeutics